Inoperable chronic thromboembolic pulmonary hypertension treated with riociguat: A case study

被引:0
|
作者
Ortiz-Bautista, Carlos [1 ]
Ochoa-Parra, Nuria [2 ]
Navas-Tejedor, Paula [2 ]
Moran-Fernandez, Laura [2 ]
Angel Gomez-Sanchez, Miguel [2 ]
机构
[1] Hosp Clin Univ, Inst Heart Sci ICICOR, Dept Cardiol, Valladolid, Spain
[2] Hosp Univ 12 Octubre, Serv Cardiol, Multidisciplinary Pulm Hypertens Unit, CIBERES, Madrid, Spain
关键词
Chronic thromboembolic pulmonary hypertension; Treatment with riociguat; Safety profile of riociguat;
D O I
10.1016/j.repc.2015.06.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 51-year-old woman presented with a one-year history of progressive dyspnea, WHO functional class III-IV and exercise-related syncope. Transthoracic echocardiography and computed tomography pulmonary angiography were performed, leading to a diagnosis of pulmonary arterial hypertension. She was referred to our pulmonary hypertension unit, where a complete study was performed, including ventilation/perfusion scan, which was consistent with chronic thromboembolic pulmonary hypertension. Risk factors for this condition were excluded and therapeutic options were evaluated. Imaging studies showed distal pulmonary disease so pulmonary endarterectomy was rejected. Further therapeutic options were evaluated and the patient was subsequently enrolled in an open-label uncontrolled trial with riociguat. After one year of treatment, significant improvement in functional class, 6-minute walk test and NT-proBNP were seen, without significant secondary effects. (C) 2015 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:777.e1 / 777.e5
页数:5
相关论文
共 50 条
  • [1] Riociguat Improves Pulmonary Hemodynamics in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension
    Tsai, Cheng-Hsuan
    Wu, Cho-Kai
    Kuo, Ping-Hung
    Hsu, Hsao-Hsun
    Chen, Zheng-Wei
    Hwang, Juey-Jen
    Ko, Chi-Lun
    Huang, Yu-Sen
    Lin, Yen-Hung
    [J]. ACTA CARDIOLOGICA SINICA, 2020, 36 (01) : 64 - 71
  • [2] Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
    Kim, Nick H.
    D'Armini, Andrea M.
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Hoeper, Marius M.
    Jansa, Pavel
    Mayer, Eckhard
    Neurohr, Claus
    Simonneau, Gerald
    Torbicki, Adam
    Wang, Chen
    Fritsch, Arno
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    [J]. HEART, 2017, 103 (08) : 599 - 606
  • [3] Economic Evaluation of Riociguat in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension
    Avxentyeva, M. V.
    Chernyavskiy, A. M.
    Pyadushkina, E. A.
    [J]. KARDIOLOGIYA, 2015, 55 (03) : 33 - 40
  • [4] Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
    Wiedenroth, Christoph B.
    Ghofrani, H. Ardeschir
    Adameit, Miriam S. D.
    Breithecker, Andreas
    Haas, Moritz
    Kriechbaum, Steffen
    Rieth, Andreas
    Hamm, Christian W.
    Mayer, Eckhard
    Guth, Stefan
    Liebetrau, Christoph
    [J]. PULMONARY CIRCULATION, 2018, 8 (03)
  • [5] Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension
    Wiedenroth, Christoph B.
    Rolf, Andreas
    Steinhaus, Kristin
    Adameit, Miriam S. D.
    Kriechbaum, Steffen D.
    Haas, Moritz
    Roller, Fritz
    Hamm, Christian W.
    Ghofrani, H. Ardeschir
    Mayer, Eckhard
    Breithecker, Andreas
    Guth, Stefan
    Liebetrau, Christoph
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (01): : 134 - 139
  • [6] Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension
    Ramos, Roberta Pulcheri
    Figueiredo, Priscila
    Ferreira, Eloara V. M.
    Messina, Carolina
    Oliveira, Rudolf
    Alberto Neder, J.
    Nery, Luiz Eduardo
    Ota Arakaki, Jaquelina Sonoe
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [7] Switching from sildenafil to riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension
    Watte, Guilherme
    Mello, Marcelo
    Altmayer, Stephan
    Hochhegger, Bruno
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 277 : 239 - 239
  • [8] Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Bishop, Bryan M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (21) : 1839 - 1844
  • [9] Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
    Ghofrani, Hossein-Ardeschir
    D'Armini, Andrea M.
    Grimminger, Friedrich
    Hoeper, Marius M.
    Jansa, Pavel
    Kim, Nick H.
    Mayer, Eckhard
    Simonneau, Gerald
    Wilkins, Martin R.
    Fritsch, Arno
    Neuser, Dieter
    Weimann, Gerrit
    Wang, Chen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04): : 319 - 329
  • [10] Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
    Ghofrani, H. A.
    Hoeper, M. M.
    Halank, M.
    Meyer, F. J.
    Staehler, G.
    Behr, J.
    Ewert, R.
    Weimann, G.
    Grimminger, F.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (04) : 792 - 799